SCHEMBL32672041

SCHEMBL32672041

O=C(Nc1cnc(OC2CC2)cn1)Oc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.47
ALDH1A1 P00352 7/20 0.42
RAB9A P51151 1/20 0.42
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
CDK5 Q00535 1/20 0.41
MAPT P10636 4/20 0.40
RAD51 Q06609 1/20 0.39
ABL1 P00519 1/20 0.39
KMT2A Q03164 3/20 0.37
MEN1 O00255 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPK1 P28482 1/20 0.37
THRB P10828 1/20 0.37
GFER P55789 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CKS1B P61024 1/20 0.37
SKP1 P63208 1/20 0.37
SKP2 Q13309 1/20 0.37
GAA P10253 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32672176 0.82 FAAH (0.45) ALDH1A1RAB9ACCNE1CDK2CDK5
SCHEMBL16776510 0.82 FAAH (0.45) ALDH1A1RAB9ACCNE1CDK2CDK5
SCHEMBL31028805 0.81 ALDH1A1 (0.50) ALDH1A1CCNE1CDK2CDK5MAPT
SCHEMBL1011423 0.81 ALDH1A1 (0.50) ALDH1A1CCNE1CDK2CDK5MAPT
SCHEMBL16775795 0.79 ALDH1A1 (0.43) ALDH1A1RAB9ACCNE1CDK2CDK5
SCHEMBL305046 0.78 NOTUM (0.52) ALDH1A1CCNE1CDK2CDK5MAPT
SCHEMBL32672056 0.78 NOTUM (0.52) ALDH1A1CCNE1CDK2CDK5MAPT
SCHEMBL2595570 0.76 CCNE1 (0.47) ALDH1A1RAB9ACCNE1CDK2CDK5
SCHEMBL21011636 0.76 FGFR4 (0.46) ABL1
SCHEMBL1009480 0.74 CCNE1 (0.45) ALDH1A1RAB9ACCNE1CDK2CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630562-B2 Piperidylurea compounds and methods of use thereof ARCUS BIOSCIENCES, INC. (US) 2026-05-19 US disclosed
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF ARCUS BIOSCIENCES, INC. (US) 2026-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630562-B2 Piperidylurea compounds and methods of use thereof CLIC1, HCCS, CNR1 GPR119 861/4885ALDH1A1 1002/4885RAB9A 767/4885
US-20260042777-A1 PIPERIDYLUREA COMPOUNDS AND METHODS OF USE THEREOF CBR1, CLIC1, RER1 GPR119 676/4885ALDH1A1 1208/4885RAB9A 485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.